E Zuber
Overview
Explore the profile of E Zuber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Korhonen P, Zuber E, Branson M, Hollaender N, Yateman N, Katiskalahti T, et al.
J Biopharm Stat
. 2012 Oct;
22(6):1258-71.
PMID: 23075021
Clinical trials in oncology often allow patients randomized to placebo to cross over to the active treatment arm after disease progression, leading to underestimation of the treatment effect on overall...
2.
Pozzo C, Barone C, Szanto J, Padi E, Peschel C, Bukki J, et al.
Ann Oncol
. 2004 Nov;
15(12):1773-81.
PMID: 15550582
Background: To identify the most effective of two combinations, irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) and irinotecan/cisplatin, in the treatment of advanced gastric cancer, for investigation in a phase III trial. Patients...
3.
Zuber E, Rosfors S
J Nucl Cardiol
. 2001 Jan;
7(6):655-60.
PMID: 11144481
Background: The aims of this study were to assess the degree of postischemic left ventricular (LV) dilatation after adenosine stress and to determine the extent to which LV volumes measured...
4.
Chang H, Hawes J, Hall G, Fuller K, FRANCOMBE W, Zuber E, et al.
Transfus Med
. 1999 Nov;
9(3):195-8.
PMID: 10555812
The transfusion management of immunocompromised patients often requires special blood product use such as cytomegalovirus (CMV)-negative cellular products, which are more costly than standard blood products and occasionally in short...
5.
Zuber E, Mathis G, Flandrois J
Anal Biochem
. 1997 Aug;
251(1):79-88.
PMID: 9300086
The easily accessible kinetics of a new homogeneous two-site fluorometric immunoassay for prolactin was studied, in order to determine its usefulness for assay data reduction and optimization. The combined use...
6.
[A case report. An unusually enlarged heart turns out to be caused not by heart failure, but a cyst]
Hedman A, Bylund H, Orre L, Zuber E, Ruiz H
Lakartidningen
. 1997 Jun;
94(26-27):2478-80.
PMID: 9235447
No abstract available.
7.
Rosso L, Zuber E, Pichat C, Flandrois J
Int J Food Microbiol
. 1997 Mar;
35(1):75-81.
PMID: 9081228
A simple relationship was observed in growth medium, between the dissociation constant (via the pKa) of the acid used to control pH and the minimum pH at which Salmonellae and...
8.
Zeder-Lutz G, Zuber E, Witz J, Van Regenmortel M
Anal Biochem
. 1997 Mar;
246(1):123-32.
PMID: 9056193
The thermodynamic parameters of the interaction between hen egg white lysozyme and Fab D1.3 were determined by measuring the temperature dependence of the ratio of its kinetic association and dissociation...
9.
Zuber E, Rosso L, Darbouret B, Socquet F, Mathis G, Flandrois J
J Immunoassay
. 1997 Feb;
18(1):21-47.
PMID: 9139047
A descriptive mathematical model was chosen to fit the antigen-antibody association kinetics of a new homogeneous immunometric assay for prolactin, involving time-resolved fluorescence detection (TRACE technology, Time Resolved Amplified Cryptate...
10.
Collins A, Haddad S, Talbot R, Herst R, Tyler B, Zuber E, et al.
Transfusion
. 1994 Jun;
34(6):517-20.
PMID: 8023393
Background: Previous studies of transfusions of newly formed red cells (neocytes) demonstrated modest extensions of transfusion interval in patients with homozygous beta-thalassemia. Study Design And Methods: The clinical benefits of...